All News

The first patient has been enrolled in a clinical trial evaluating IMNN-001, an immunotherapy, combined with Avastin for the treatment of advanced ovarian cancer.

On multiple occasions, doctors told me not to worry, but I ended up being diagnosed with a rare cancer called leiomyosarcoma.

With a wink and wearing a mischievous smile, my friend “Charley” likes to relate how he learned about his diagnosis of prostate cancer several years ago.

After a patient receives a kidney cancer diagnosis, there are some important conversations to have with their health care team.

Cancer survivors who are experiencing side effects from treatment, such as chronic fatigue, may benefit from a healthier diet.

The best of humanity met me at the worst time of my life when I found “my people” after receiving a stage 4 colorectal cancer diagnosis.

On Feb. 6, HB 2783 was introduced into the Arizona House. Hopefully this bill will help address some of the issues surrounding genetic testing, genetic counseling, and insurance coverage for those who might be at risk for hereditary cancer. My wife died of a cancer that was totally preventable. Nobody should die of a preventable cancer.

Researchers are recruiting patients with ER-positive, HER2-negative breast cancer to participate in a trial evaluating (Z)-endoxifen.

As a part of its Speaking Out Video series, CURE® spoke with Terri Conneran, on behalf of KRAS Kickers, about networking during a lung cancer diagnosis.

As a part of its Speaking Out Video series, CURE® spoke with Terri Conneran, on behalf of KRAS Kickers, about what biomarker testing is and why patients with lung cancer should advocate for themselves during that process.

As a part of its Speaking Out Video series, CURE® spoke with Terri Conneran, on behalf of KRAS Kickers, about the importance of second opinions during a lung cancer diagnosis.

A combination of the blood pressure medication, Cozaar, to a chemo regimen is more effective in reducing genes related to immunosuppression and invasion than chemo alone, study results show.

I’m in the race of cancer, hoping that a cure will pass the finish line before I do.

From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.

The novel targeted radiotherapy iomab-B led to the disappearance of all signs of cancer and an improvement in event-free survival compared with physician’s choice of treatment.

The designation is based on study findings demonstrating that the cancer vaccine-Keytruda combination reduces the risk of recurrence or death by 44% in the adjuvant setting for patients with melanoma.

Karen Estrada was shocked when she was diagnosed with leukemia and ended up on a lifesaving clinical trial, although her journey was not entirely smooth.

As unlucky as I was to be diagnosed with pancreatic cancer, I'm extremely thankful to still be here today.

Patients who used opioids long-term after undergoing an autologous stem cell transplant tended to have poorer survival outcomes, recent research showed.

Standard corticosteroid use may not be the best treatment for patients with cancer who experience immunotherapy-related heart issues, research showed.

A book I read made me realize the importance of positive thinking — even when going through cancer.

Patients with type 2 diabetes have an increased cancer burden and, as a result, a higher mortality rate, highlighting the importance of inflammatory factors like obesity and glucose control.

While undergoing cancer treatments, I wasn’t prepared for what it would feel like while interacting with the world outside of the hospital, but I found a few things that helped.

An expert explains what patients with low-grade prostate cancer can expect when undergoing genomic testing — and why the procedure is important.

Important data may encourage gender-specific treatment making decisions for patients with bladder cancer.

A clinical trial is currently enrolling patients who are experiencing hand-foot skin reaction as a result of kidney cancer treatment.

An expert discusses the value of Jaypirca’s recent accelerated FDA approval for relapsed/refractory mantle cell lymphoma, as well as where treatment may go next.

Sometimes the steps I take leaving the hospital make me feel like I’m flying if I received good news, but other times, I’m walking quickly to my car before I begin to cry.